Historical Stock Price
ETFs Holding AIMT »    AIMT Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
02/16/2018 $38.16 $38.66 $36.99 $37.20 261.50K
02/20/2018 $41.10 $42.00 $33.45 $34.96 5.36M
02/21/2018 $34.01 $34.24 $32.20 $32.21 2.46M
02/22/2018 $34.69 $36.00 $31.50 $31.98 7.66M
02/23/2018 $32.21 $32.83 $30.40 $32.72 2.68M
Aimmune Therapeutics is a clinical-stage biopharmaceutical company focused on a therapeutic approach that includes the development of proprietary product candidates for the treatment of peanut and other food allergies. Co.'s therapeutic approach, Characterized Oral Desensitization Immunotherapy (CODIT™), is designed to desensitize patients to food allergens and thereby reduce the risk of having an allergic reaction upon accidental exposure, or reduce symptom severity should an allergic reaction occur. Co. is developing its CODIT product candidate, AR101, for the treatment of peanut allergy.
AIMT historical stock prices picture
Aimmune Therapeutics (AIMT) has the following price history information. Looking back at AIMT historical stock prices for the last five trading days, on February 16, 2018, AIMT opened at $38.16, traded as high as $38.66 and as low as $36.99, and closed at $37.20. Trading volume was a total of 261.50K shares. On February 20, 2018, AIMT opened at $41.10, traded as high as $42.00 and as low as $33.45, and closed at $34.96. Trading volume was a total of 5.36M shares. On February 21, 2018, AIMT opened at $34.01, traded as high as $34.24 and as low as $32.20, and closed at $32.21. Trading volume was a total of 2.46M shares. On February 22, 2018, AIMT opened at $34.69, traded as high as $36.00 and as low as $31.50, and closed at $31.98. Trading volume was a total of 7.66M shares. On February 23, 2018, AIMT opened at $32.21, traded as high as $32.83 and as low as $30.40, and closed at $32.72. Trading volume was a total of 2.68M shares.

AIMT Historical Stock Prices By Date:

AIMT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aimmune Therapeutics shares, starting with a $10,000 purchase of AIMT, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/06/2015
End date: 02/23/2018
Start price/share: $24.10
End price/share: $32.72
Dividends collected/share: $0.00
Total return: 35.77%
Average Annual Total Return: 12.72%
Starting investment: $10,000.00
Ending investment: $13,576.27
Years: 2.55
Date Close
02/16/2018$37.20
02/20/2018$34.96
02/21/2018$32.21
02/22/2018$31.98
02/23/2018$32.72
AIMT is categorized under the Healthcare sector; below are some other companies in the same sector:

AIQ Historical Stock Prices
AIRM Historical Stock Prices
AKAO Historical Stock Prices
AKBA Historical Stock Prices
AKCA Historical Stock Prices
AKER Historical Stock Prices
AKRX Historical Stock Prices
ALBO Historical Stock Prices
ALC Historical Stock Prices
ALDR Historical Stock Prices

AIMT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.